卫信康 (603676)

Xizang Weixinkang Pharmaceutical Co., Ltd.

ASH

Tags

Generic DrugsChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareHigh-Performing StocksVitamins

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 43516.15
  • Circulating A-Shares(W): 43516.15
  • Earnings Per Share(RMB): 0.5100
  • Net Assets Per Share(RMB): 3.5078
  • Operating Revenue(W RMB): 86241.68
  • Total Profit(W RMB): 26819.30
  • **Net Profit Attributable to Parent(W RMB) **: 21917.70
  • Net Profit Growth Rate(%): -9.90
  • Weighted Return on Equity(%): 15.0100
  • Operating Cash Flow Per Share(RMB): 0.2610
  • Undistributed Profit Per Share(RMB): 1.5588
  • Capital Reserve Per Share(RMB): 0.7989

2. Main Business

The main business covers:

  • Research, production, and sales of chemical drug preparations and their active pharmaceutical ingredients
  • Intravenous vitamin supplements
  • Intravenous electrolyte supplements
  • Intravenous iron supplements
  • Liver-protecting drugs
  • Antibiotic products

3. Company Basic Information

  • Company Name: Tibet Weixinkang Pharmaceutical Co., Ltd.
  • Listing Date: 2017-07-21
  • Industry: Pharmaceutical Manufacturing
  • Address: 3rd Floor, Building 4, Industrial Center, No. 5 South Road, Zone B, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region
  • Website: http://www.wxkpharma.com
  • Company Profile: The company was established by eight shareholders, including Tibet Zhongweikang Investment, through a overall change. On November 24, 2015, Weixinkang Limited held a shareholders' meeting and resolved to convert the company's audited net assets of 391.1447 million yuan as of July 31, 2015, into 200 million shares of the joint-stock company, with a par value of 1 yuan per share. The portion of net assets exceeding the registered capital, 191.1447 million yuan, was recorded as the company's capital reserve. Weixinkang Limited was transformed into a joint-stock company. The capital contributions of the eight founding shareholders during this transformation were verified by Ruihua Certified Public Accountants' Capital Verification Report (Ruihua Yan Zi [2015] No. 01300064) issued on November 24, 2015, and the company obtained the Business License with Unified Social Credit Code 91540091785815591P from the Lhasa Economic and Technological Development Zone Administration for Industry and Commerce on December 2, 2015.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Tibet Weixinkang Enterprise Management Co., Ltd. General Legal Person 20524.90 47.17
2 Tianjin Jingweixinkang Management Consulting Partnership (Limited Partnership) General Legal Person 3373.44 7.75
3 Xiangcai Pharmaceutical Health Hybrid Securities Investment Fund Class A Fund 27.10 0.06

5. Concept Sectors

  • Vitamins
  • Generic Drugs

Remarks

  • Data update date: 2025-10-30
  • Data source: Public market information